In today's interview, we have the pleasure of speaking with James Maitland, a renowned expert in robotics and IoT applications in medicine. His dedication to using technology for healthcare innovation has had a transformative impact on the field. This interview delves into his insights on
Boston Scientific's strategic exit from its transcatheter aortic valve replacement systems has sparked significant discussion within the medical technology sector. This move, influenced by regulatory hurdles and competitive trials, leaves a considerable gap for other industry players to explore.
A groundbreaking stride in Alzheimer's diagnostics has taken center stage with the U.S. Food and Drug Administration's recent clearance of a non-invasive blood test designed to detect early signs of the disease. Developed by Fujirebio Diagnostics, this test evaluates specific biomarkers in blood
James Maitland, a distinguished expert in the field of robotics and IoT applications within the healthcare industry, joins us today to unravel the complex interplay of technology and policy in shaping the future of healthcare. While his expertise stretches far into the realm of innovation, today’s
James Maitland, a renowned authority on robotics and Internet of Things applications in medicine, brings a wealth of knowledge to the conversation on leveraging technology in healthcare. With a keen insight into current trends, Maitland offers a unique perspective on the intricacies of deploying
As the global population ages and disabilities become increasingly prevalent, the need for effective rehabilitation methodologies is more pressing than ever. Robotics holds promise in addressing these challenges, offering innovative ways to assist individuals with motor, sensory, and cognitive
